Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,203.20
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
100.77
(
-0.43%
)
Bitcoin
77,750.66
(
-0.67%
)
News Focus
News Focus
Post# of 822657
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

CrashOverride

Send PM Follow Ignore
Followers 96
Posts 5080
Boards Moderated 0
Alias Born 02/07/2021

CrashOverride

Re: CrashOverride post# 555952

Tuesday, 01/03/2023 3:00:42 PM

Tuesday, January 03, 2023 3:00:42 PM

Post# of 822657
NICE told me May 11 2022:


It is important to note that we can only appraise drugs that have a marketing authorisation for the treatment of a particular indication or are expected to receive one during our appraisal process, and can only issue final guidance on drugs that have a marketing authorisation.


 

Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News